Galen L. Wampler
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Genetics top 5%
- Epidemiology
- Co-authors
- Solomon ZimmTapan A. HazraHarold F. YoungBart van’t RietHoward L. ElfordC. DjordjevićWalter H. CarterP. CATSOULACOS
- Topics
- Lung Cancer Treatments and Mutations (12 papers)Cancer therapeutics and mechanisms (10 papers)Statistical Methods in Clinical Trials (10 papers)
- Journals
- Journal of Clinical OncologyJournal of the American Statistical AssociationJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesGreeceGermany
In The Last Decade
Galen L. Wampler
54 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 760
- Pulmonary and Respiratory Medicine 579
- Molecular Biology 441
- Genetics 314
- Epidemiology 227
Countries citing papers authored by Galen L. Wampler
This map shows the geographic impact of Galen L. Wampler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen L. Wampler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen L. Wampler more than expected).
Fields of papers citing papers by Galen L. Wampler
This network shows the impact of papers produced by Galen L. Wampler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen L. Wampler. The network helps show where Galen L. Wampler may publish in the future.
Co-authorship network of co-authors of Galen L. Wampler
This figure shows the co-authorship network connecting the top 25 collaborators of Galen L. Wampler. A scholar is included among the top collaborators of Galen L. Wampler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galen L. Wampler. Galen L. Wampler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 90 | |
| 3 | 154 | |
| 4 | 9 | |
| 5 | 11 | |
| 6 | 4 | |
| 7 | 4 | |
| 8 | 15 | |
| 9 | 23 | |
| 10 | 45 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 34 | |
| 15 | 26 | |
| 16 | Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer. | 24 |
| 17 | 17 | |
| 18 | Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. | 57 |
| 19 | 5 | |
| 20 | Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response. | 40 |
About Galen L. Wampler
Galen L. Wampler is a scholar working on Statistics and Probability, Oncology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer therapeutics and mechanisms (10 papers) and Statistical Methods in Clinical Trials (10 papers). The work is most often cited by research in Genetics (314 citations), Oncology (760 citations) and Pulmonary and Respiratory Medicine (579 citations). Galen L. Wampler has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Solomon Zimm, Tapan A. Hazra, Harold F. Young, Bart van’t Riet, Howard L. Elford, C. Djordjević, Walter H. Carter, P. CATSOULACOS, Donald M. Stablein and William Regelson. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.